Medscape Medical NewsAll articles

Annalise Enterprise CXR Triage Trauma

Annalise-AI Pty Ltd • Radiology • 03/28/2023

510(k)IEC 62304 Class B
FDA Summary PDF

Device Purpose

Annalise Enterprise CXR Triage Trauma is a software tool utilizing a deep-learning artificial intelligence algorithm to analyze adult chest X-rays for features suggestive of vertebral compression fractures, aiming to prioritize these cases in clinical worklists. The system integrates with PACS/RIS and demonstrated high diagnostic accuracy (AUC 0.954) and specific sensitivity/specificity performance in identifying vertebral compression fractures from erect CXRs, thereby facilitating expedited review for clinicians in specialized bone health programs.

Summary

Annalise Enterprise CXR Triage Trauma is an AI-powered software workflow tool designed to assist clinicians in the medical care environment. Its primary function is to analyze adult chest X-ray (CXR) studies to identify features suggestive of vertebral compression fractures. The system employs a convolutional neural network, trained using deep-learning techniques on diverse datasets, to detect these findings. Upon identification, the device integrates with existing Picture Archiving and Communication Systems (PACS) or Radiology Information Systems (RIS) to provide case-level output, enabling worklist prioritization or triage, specifically for clinicians in Bone Health and Fracture Liaison Service programs. It operates in parallel with standard clinical workflows and is not intended for standalone diagnostic decision-making, to direct attention to specific image portions other than vertebral compression fractures, or to rule out other critical findings. The device's performance was validated through a standalone, retrospective study using 589 CXR cases (272 positive for vertebral compression fracture, 317 negative) independent of the training data, sourced from four US hospital networks, with ground truth established by board-certified radiologists. For vertebral compression fractures, the AI algorithm demonstrated an Area Under the Curve (AUC) of 0.954 (95% CI: 0.939-0.968). At specific operating points, it achieved sensitivities of 89.3% (95% CI: 85.7-93.0) and 85.3% (95% CI: 80.9-89.3) with corresponding specificities of 89.0% (95% CI: 85.8-92.1) and 90.9% (95% CI: 87.7-94.0) respectively. The system also showed an average triage turn-around time of 30.0 seconds, though a noted limitation is that the performance evaluation was conducted using only erect positioning CXRs, and performance with supine positioning may differ.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

Artificial IntelligenceChest X-rayVertebral Compression FractureTriageWorklist PrioritizationConvolutional Neural NetworkDeep LearningPACS IntegrationSensitivitySpecificity

Device Metadata

Submission Number
K222268
Company
Annalise-AI Pty Ltd
Panel
Radiology
Product Code
N/A
Data Type
Images
Clinical Function
Assessment
AI Function
Analysis
AI Subclass
triage

Relevant Clinical Questions

  • Q1. How does the device's performance change when analyzing CXRs taken with supine positioning, given the current evaluation was limited to erect positioning?; What specific impact does the 30-second average triage turn-around time have on overall patient management and outcomes in Bone Health and Fracture Liaison Service programs?; Beyond vertebral compression fractures, are there plans to expand the AI algorithm's capability to detect other subtle or commonly missed traumatic findings on chest X-rays?; How does the algorithm differentiate between acute and chronic vertebral compression fractures, or does it flag all such fractures regardless of suspected acuity?; What were the characteristics of the false positive and false negative cases in the standalone performance study for vertebral compression fractures, and what strategies could further refine the algorithm's accuracy?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score15/100
SBOM Evidence⚠ Not mentioned in summary
Cyber Risk Assessment⚠ Not mentioned in summary
Postmarket Plan⚠ Not mentioned in summary
§524B ApplicableNo

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials(training data, deep learning, neural network, algorithm, dataset)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials(network)
✓ Detected
HBOMHardware Bill of Materials
- Not detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials(environment)
✓ Detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of ML-BOM, SaaSBOM, OBOM detected in AI-generated device summary.

• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.

• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.

• Not detected in AI-generated device summary: SBOM, HBOM, CBOM, VDR/VEX. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
Annalise Enterprise CXR Triage Trauma - Annalise-AI Pty Ltd | ESL FDA AI Device Intelligence